Status:
ENROLLING_BY_INVITATION
Studio TIARA: Alessitimia ed Emicrania Cronica
Lead Sponsor:
Azienda Sanitaria Locale di Alessandria
Conditions:
Migraine
Alexithymia
Eligibility:
FEMALE
12-65 years
Brief Summary
The aim of this observational, cross-sectional study is to investigate the relationship between alexithymia and migraine frequency (considering alexithymia a condition that can influence the severity ...
Eligibility Criteria
Inclusion
- Diagnosis of episodic migraine with or without aura, chronic migraine and/or MOH according to ICHD-3 2018 criteria;
- Patients aged 12-65 years;
- Female patients
Exclusion
- Ongoing major depressive episode;
- Comorbidities for major internal diseases (hepatopathy, nephropathy, heart failure, etc.);
- Alcohol or substance abuse disorder (eoin, cocaine, cannabis, hallucinogens);
- Language barrier;
- Low cultural/cognitive level;
- No informed consent.
Key Trial Info
Start Date :
May 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06891053
Start Date
May 30 2022
End Date
December 31 2025
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Sanitaria Locale di Alessandria (ASL AL)
Alessandria, Italy, Italy, 15121